Colorectal Cancer
Conditions
Keywords
colorectal cancer
Brief summary
Clinical study participation percentages haven't always been fully representative of a given demographic. Participation in this observational clinical research is extremely valuable since it allows people with colorectal cancer to contribute their own experiences and unique viewpoints. These vital contributions have the potential to affect the development of novel therapies and support services dramatically. Trial's findings will be critical in furthering the understanding of colorectal cancer, ultimately leading to better patient outcomes.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Participant has a diagnosis of colorectal cancer * Patient has self-identified as planning to enroll in a clinical trial for colorectal cancer * Patient is at least 18 years of age
Exclusion criteria
* Inability to perform regular electronic reporting * Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial * Pregnant or lactating woman
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of colorectal cancer patients who remain in clinical trial until completion. | 12 months |
| Rate of patients who decide to enroll in a colorectal cancer clinical study. | 3 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed